Literature DB >> 33587954

Neuroendocrine, neuroinflammatory and pathological outcomes of chronic stress: A story of microglial remodeling.

Katherine Picard1, Marie-Kim St-Pierre1, Haley A Vecchiarelli2, Maude Bordeleau3, Marie-Ève Tremblay4.   

Abstract

Microglia, the resident macrophage cells of the central nervous system (CNS), are involved in a myriad of processes required to maintain CNS homeostasis. These cells are dynamic and can adapt their phenotype and functions to the physiological needs of the organism. Microglia rapidly respond to changes occurring in their microenvironment, such as the ones taking place during stress. While stress can be beneficial for the organism to adapt to a situation, it can become highly detrimental when it turns chronic. Microglial response to prolonged stress may lead to an alteration of their beneficial physiological functions, becoming either maladaptive or pro-inflammatory. In this review, we aim to summarize the effects of chronic stress exerted on microglia through the neuroendocrine system and inflammation at adulthood. We also discuss how these effects of chronic stress could contribute to microglial involvement in neuropsychiatric and sleep disorders, as well as neurodegenerative diseases.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic stress; Glucocorticoids; Microglia; Neurodegenerative diseases; Neuroinflammation; Neuropsychiatric disorders

Year:  2021        PMID: 33587954     DOI: 10.1016/j.neuint.2021.104987

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  12 in total

Review 1.  Psychosis spectrum illnesses as disorders of prefrontal critical period plasticity.

Authors:  Sophia Vinogradov; Matthew V Chafee; Erik Lee; Hirofumi Morishita
Journal:  Neuropsychopharmacology       Date:  2022-09-30       Impact factor: 8.294

Review 2.  Microglia as a Hub for Suicide Neuropathology: Future Investigation and Prevention Targets.

Authors:  Elisa Gonçalves de Andrade; Fernando González Ibáñez; Marie-Ève Tremblay
Journal:  Front Cell Neurosci       Date:  2022-05-18       Impact factor: 6.147

Review 3.  Dual Roles of Microglia in the Basal Ganglia in Parkinson's Disease.

Authors:  Mohammed E Choudhury; Yuka Kigami; Junya Tanaka
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

Review 4.  Brain-body responses to chronic stress: a brief review.

Authors:  Brandon L Roberts; Ilia N Karatsoreos
Journal:  Fac Rev       Date:  2021-12-16

5.  Glial Cell Activation and Oxidative Stress in Retinal Degeneration Induced by β-Alanine Caused Taurine Depletion and Light Exposure.

Authors:  Ana Martínez-Vacas; Johnny Di Pierdomenico; Francisco J Valiente-Soriano; Manuel Vidal-Sanz; Serge Picaud; María Paz Villegas-Pérez; Diego García-Ayuso
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

Review 6.  Dysregulation of mTOR Signaling after Brain Ischemia.

Authors:  Mario Villa-González; Gerardo Martín-López; María José Pérez-Álvarez
Journal:  Int J Mol Sci       Date:  2022-03-04       Impact factor: 5.923

Review 7.  The behavior and functions of embryonic microglia.

Authors:  Yuki Hattori
Journal:  Anat Sci Int       Date:  2021-09-19       Impact factor: 1.741

8.  Microglial Engulfment of Spines in the Ventral Zona Incerta Regulates Anxiety-Like Behaviors in a Mouse Model of Acute Pain.

Authors:  Zahra Farzinpour; An Liu; Peng Cao; Yu Mao; Zhi Zhang; Yan Jin
Journal:  Front Cell Neurosci       Date:  2022-07-14       Impact factor: 6.147

9.  Genotype Load Modulates Amyloid Burden and Anxiety-Like Patterns in Male 3xTg-AD Survivors despite Similar Neuro-Immunoendocrine, Synaptic and Cognitive Impairments.

Authors:  Aida Muntsant; Lydia Giménez-Llort
Journal:  Biomedicines       Date:  2021-06-23

Review 10.  Glial Cells as Therapeutic Approaches in Brain Ischemia-Reperfusion Injury.

Authors:  Ivó H Hernández; Mario Villa-González; Gerardo Martín; Manuel Soto; María José Pérez-Álvarez
Journal:  Cells       Date:  2021-06-30       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.